Ipilimumab/nivolumab/pembrolizumab

Ipilimumab/nivolumab/pembrolizumab Reactions 1704, p209 - 2 Jun 2018 troponin-T level. His unspecified statin treatment was discontinued but his condition worsened along with development of myalgia and dyspnoea. A repeat laboratory investigation revealed further increase in the creatine Various toxicities: 9 case reports phosphokinase and liver enzyme levels. His CRP level was also In a retrospective review study, nine patients (7 men and elevated. On the fourth day of hospitalisation, a muscle biopsy 2 women) aged 19 76 years were described who developed showed necrotic muscle fibres with infiltration by meningoencephalitis, limbic encephalitis, myositis with macrophages and T-lymphocytes. An echocardiogram cardiac complications including cardiac arrhythmia, revealed regional wall motion abnormality with an estimated polyradiculitis, ocular myasthenic syndrome, reactivated left ventricular ejection fraction of 50%. His pembrolizumab myasthenia, rash or cranial polyneuropathy during treatment treatment was discontinued. He was then treated with bilevel with ipilimumab, nivolumab or pembrolizumab [routes not positive airway pressure support, but his respiratory condition stated; not all dosages stated]. Two patients eventually died continued to deteriorate. Therefore, myositis and cardiac due to cardiac arrhythmia or myasthenic syndrome and septic complications as possible immune-related adverse events due shock. to pembrolizumab were suspected. He started receiving Patient 1: A 68-year-old http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Reactions Weekly Springer Journals

Ipilimumab/nivolumab/pembrolizumab

Reactions Weekly , Volume 1704 (1) – Jun 2, 2018

Loading next page...
 
/lp/springer_journal/ipilimumab-nivolumab-pembrolizumab-d9QTZoc4Xl
Publisher
Springer Journals
Copyright
Copyright © 2018 by Springer International Publishing AG, part of Springer Nature
Subject
Medicine & Public Health; Drug Safety and Pharmacovigilance; Pharmacology/Toxicology
ISSN
0114-9954
eISSN
1179-2051
D.O.I.
10.1007/s40278-018-46852-3
Publisher site
See Article on Publisher Site

Abstract

Reactions 1704, p209 - 2 Jun 2018 troponin-T level. His unspecified statin treatment was discontinued but his condition worsened along with development of myalgia and dyspnoea. A repeat laboratory investigation revealed further increase in the creatine Various toxicities: 9 case reports phosphokinase and liver enzyme levels. His CRP level was also In a retrospective review study, nine patients (7 men and elevated. On the fourth day of hospitalisation, a muscle biopsy 2 women) aged 19 76 years were described who developed showed necrotic muscle fibres with infiltration by meningoencephalitis, limbic encephalitis, myositis with macrophages and T-lymphocytes. An echocardiogram cardiac complications including cardiac arrhythmia, revealed regional wall motion abnormality with an estimated polyradiculitis, ocular myasthenic syndrome, reactivated left ventricular ejection fraction of 50%. His pembrolizumab myasthenia, rash or cranial polyneuropathy during treatment treatment was discontinued. He was then treated with bilevel with ipilimumab, nivolumab or pembrolizumab [routes not positive airway pressure support, but his respiratory condition stated; not all dosages stated]. Two patients eventually died continued to deteriorate. Therefore, myositis and cardiac due to cardiac arrhythmia or myasthenic syndrome and septic complications as possible immune-related adverse events due shock. to pembrolizumab were suspected. He started receiving Patient 1: A 68-year-old

Journal

Reactions WeeklySpringer Journals

Published: Jun 2, 2018

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off